Mankind Pharma Incorporates Wholly Owned Subsidiary in Netherlands
Mankind Pharma Limited has successfully incorporated its proposed wholly owned subsidiary in the Netherlands. The company confirmed the establishment of the new entity on August 13, 2026.The newly incorporated subsidiary operates under the name and style of Mankind Pharma (Netherlands) B.V. This step completes the incorporation process for the entity within the Netherlands.
MANKIND Stock Price Movement
On Thursday, shares of Mankind Pharma Limited shed value, settling at ₹2404.4 after slipping 1.18% in trading. The stock saw a considerable volume flow on the day, with 129,086 shares recorded during trading.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.